Black Diamond Group Limited (BDIMF)
OTCMKTS · Delayed Price · Currency is USD
12.10
+0.36 (3.07%)
Feb 9, 2026, 3:54 PM EST
Black Diamond Group Revenue
Black Diamond Group had revenue of 105.32M CAD in the quarter ending September 30, 2025, with 4.08% growth. This brings the company's revenue in the last twelve months to 445.65M, up 19.27% year-over-year. In the year 2024, Black Diamond Group had annual revenue of 403.00M with 2.41% growth.
Revenue (ttm)
445.65M CAD
Revenue Growth
+19.27%
P/S Ratio
2.62
Revenue / Employee
878.99K CAD
Employees
507
Market Cap
836.85M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 403.00M | 9.49M | 2.41% |
| Dec 31, 2023 | 393.51M | 68.96M | 21.25% |
| Dec 31, 2022 | 324.54M | -15.01M | -4.42% |
| Dec 31, 2021 | 339.55M | 159.69M | 88.79% |
| Dec 31, 2020 | 179.86M | -6.08M | -3.27% |
| Dec 31, 2019 | 185.94M | 20.01M | 12.06% |
| Dec 31, 2018 | 165.93M | 12.55M | 8.19% |
| Dec 31, 2017 | 153.38M | 784.00K | 0.51% |
| Dec 31, 2016 | 152.59M | -129.59M | -45.92% |
| Dec 31, 2015 | 282.19M | -104.38M | -27.00% |
| Dec 31, 2014 | 386.57M | 39.51M | 11.38% |
| Dec 31, 2013 | 347.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GMéxico Transportes | 3.59B |
| DBM Global | 460.70M |
| Mestek | 299.77M |
| Paul Mueller Company | 263.33M |
| Siem Industries | 224.73M |
| Butler National | 86.16M |
| Scope Industries | 77.00M |
| Sino Green Land | 1.33M |
Black Diamond Group News
- 7 days ago - Black Diamond Group Limited Announces Timing of Fourth Quarter and Year-End 2025 Financial Results and Conference Call - GlobeNewsWire
- 4 weeks ago - What Makes Black Diamond (BDTX) a New Strong Buy Stock - Nasdaq
- 2 months ago - Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data - Benzinga
- 2 months ago - Black Diamond To Present Phase 2 Data Of Silevertinib In Non-small Cell Lung Cancer Today - Nasdaq
- 3 months ago - Black Diamond Group Limited Announces Closing of Royal Camp Services Acquisition - GlobeNewsWire
- 3 months ago - Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run? - Nasdaq
- 3 months ago - Black Diamond (BDTX) Projects Financial Stability Through 2027 - GuruFocus
- 3 months ago - Black Diamond Group Limited (BDI:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha